Dermatitis News and Research

Latest Dermatitis News and Research

Mylan, Shionogi and CIMA Labs to resolve generic Orapred ODT patent litigation

Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.

10 Oct 2012

Researchers discover 8 new loci associated with susceptibility to atopic dermatitis

Researchers at the RIKEN Center for Genomic Medicine (CGM) and their colleagues have identified 8 new loci associated with susceptibility to atopic dermatitis in the Japanese population.

8 Oct 2012

Gestational age and weight influence early atopic dermatitis risk

High birthweight and having a gestational age older than 40 weeks increases a baby’s risk for developing atopic dermatitis, suggest results from two meta-analyses presented at the European Academy of Dermatology and Venereology annual congress in Prague, Czech Republic.

4 Oct 2012

Coding the way to better occupational allergy care

The 11th draft of the International Classification of Diseases, due to be released in 2015, will allow a much more detailed specification of occupational allergy and contact dermatitis than the current draft, say dermatologists involved in the revision.

1 Oct 2012

Provectus amends and expands protocol for PV-10 Phase 1 hepatocellular carcinoma study

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that it has amended and expanded the scope of the protocol PV-10-LC-01, "A Phase 1 Study to Assess the Safety, Tolerability and Pharmacokinetics of PV-10 Chemoablation of Cancer Metastatic to the Liver or Hepatocellular Carcinoma not Amenable to Resection or Transplant."

28 Sep 2012

New spray could help avoid contact dermatitis

With more than half of all adults allergic to poison ivy, oak and sumac, scientists are reporting an advance toward an inexpensive spray that could reveal the presence of the rash-causing toxic oil on the skin, clothing, garden tools, and even the family cat or dog. Using the spray, described in ACS' The Journal of Organic Chemistry would enable people to wash off the oil, or avoid further contact, in time to sidestep days of misery.

27 Sep 2012

Nottingham expert to study impact of gluten intolerance on patients in the UK

A University of Nottingham expert has been awarded -80,000 by two national charities to study the impact of gluten intolerance on patients in the UK.

27 Sep 2012

Low-cost thermometer identifies cows with poor hoof health

A low-cost hand-held infrared thermometer can successfully identify cows with potentially treatable hoof lesions, report researchers in the Veterinary Record.

26 Sep 2012

Advanced optics system noninvasively maps out network of tiny blood vessels beneath the skin

The trained eye of a dermatologist can identify many types of skin lesions, but human sight only goes so far. Now an international team of researchers has developed an advanced optics system to noninvasively map out the network of tiny blood vessels beneath the outer layer of patients' skin, potentially revealing telltale signs of disease.

24 Sep 2012

Friendly bacteria: do we really need to eat probiotic yogurts?

According to the World Health Organization (WHO) probiotics are “live microorganisms which when administered in adequate amounts confer a health benefit on the host”.

19 Sep 2012

Hebrew University researcher develops anti-inflammatory and anti-allergic family of drugs

A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.

7 Sep 2012

Interleukin-18 plays a key role in inflammation

The naturally occurring cytokine interleukin-18, or IL-18, plays a key role in inflammation and has been implicated in serious inflammatory diseases for which the prognosis is poor and there are currently limited treatment options.

7 Sep 2012

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

Alfa Wassermann, Salix enter license agreement for EIR formulation of rifaximin

Salix Pharmaceuticals, Ltd. and Alfa Wassermann S.p.A. today announced that they have entered into an exclusive agreement by which Salix has licensed rights in the United States and Canada to an extended intestinal release (EIR) formulation of rifaximin for gastrointestinal and respiratory indications, including Crohn's disease.

9 Aug 2012

Shampoo effective for pruritus relief in dogs

Shampooing dogs with pruritus is an effective method to reduce symptoms even if the shampoo does not contain any active ingredients, report researchers in Veterinary Record.

1 Aug 2012

Ansell introduces GAMMEX Non-Latex Accelerator-Free Sensitive surgical glove with SENSOPRENE

Ansell Ltd., a global leader in protection solutions, has today introduced a ground-breaking new SENSOPRENE formulation, with the launch of its GAMMEX Non-Latex Accelerator-Free Sensitive surgical glove.

30 Jul 2012

Study clarifies anti-inflammatory impact of boswellic acids

It was one of the gifts of the Magi - in addition to myrrh and gold they offered frankincense to the newly born baby Jesus. Since the ancient world the aromatic fragrance of burning Boswellia resin has been part of many religious ceremonies and is still used as a means to indicate special festive atmosphere in the church today. But frankincense can do much more: "The resin from the trunk of Boswellia trees contains anti-inflammatory substances," Professor Dr. Oliver Werz of the Friedrich Schiller University Jena (Germany) says.

10 Jul 2012

Global warming may stimulate growth of cyanobacteria

Cyanobacteria are among the most primitive living beings, aged over 3,500 million years old. These aquatic microorganisms helped to oxygenate the earth-atmosphere. At present their populations are increasing in size without stopping. It appears that global warming may be behind the rise in their numbers and may also lead toan increase in the amount of toxins produced by some of these populations.

4 Jul 2012

Top-line final data from Provectus’ PV-10 phase 2 trial on metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that top-line final data from its phase 2 clinical trial of PV-10 for metastatic melanoma were presented at the 2nd European Post-Chicago Melanoma Meeting 2012, Interdisciplinary Global Conference on Developing New Treatments for Melanoma, on June 22, 2012, in Munich, Germany.

27 Jun 2012

Sunflower peptides can treat itchy skin problems

Sunflowers may hold the solution to a problem which gets under the skin of millions of Australians every year. Skin conditions such as eczema, dermatitis, rosacea and the lesser-known Netherton Syndrome pose an itchy problem for many sufferers world-wide, but a group of researchers from Queensland University of Technology (QUT), in Brisbane Australia, are looking at ways to soothe the problem - with tiny proteins called peptides, found in sunflowers.

26 Jun 2012